Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in patients with Type 2 diabetes.

Share this story:

This post was originally published here